MOUNJARO KWIKPEN 12.5MG/0.6ML INJECTION IN PRE-FILLED PEN 1'S

• Mounjaro (Tirzepatide) KwikPen is a prescription medication used for managing type 2 diabetes.
• It is administered as a subcutaneous injection and is designed to help improve blood sugar control.
  

Active Ingredient:

• Tirzepatide: A novel medication that targets both GIP and GLP-1 receptors to regulate blood sugar levels.

Dosage Form:

• Pre-filled pen for subcutaneous injection.
• Contains 12.5mg of tirzepatide in 0.6ml solution.

1. Combination Therapy:

   • Mounjaro is a dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist.
   • It helps enhance insulin secretion and suppress glucagon release, improving blood sugar control.

2. Convenient Dosage Form:

   • Comes in a pre-filled pen, making it easy to use.
   • Each pen contains 12.5mg of tirzepatide in 0.6ml solution, providing a precise dose.

3. Flexible Dosing:

   • Typically administered once weekly.
   • Dosing can be adjusted based on patient response and tolerance.